Professor Wojciech Fendler, MD, PhD, has assumed the position of Co-Chair of the Prix Galien Poland Award Committee. He will serve in this role jointly with Professor CezarySzczylik, MD, PhD.

(Warsaw, 11 January 2026) Professor Wojciech Fendler, MD, PhD, President of the Medical Research Agency of Poland, has been appointed Co-Chair of the Prix Galien Poland Award Committee. He will share this responsibility with the current Chair, Professor Cezary Szczylik, MD, PhD. This appointment reflects the alignment of the Prix Galien Poland Award Committee with the international governance model of the Galien Foundation.

Professor Wojciech Fendler, MD, PhD

"Assuming the role of Co-Chair of the Prix Galien Poland Award Committee is a great honorfor me. Prix Galien is an institution with a unique history spanning more than fifty years and iswidely recognized as the world’s most prestigious award in medical and pharmaceuticalinnovation. It is an initiative that consistently promotes solutions that meaningfully transformclinical practice and improve patients’ quality of life,” said Professor Fendler.

"I am very pleased to share this distinguished, though demanding, role with Professor Wojciech Fendler. His scientific expertise, leadership experience, and strong commitment to advancing innovation in healthcare will be an invaluable asset to the work of the Prix Galien Poland Award Committee,” said Professor Cezary Szczylik.

Professor Wojciech Fendler, MD, PhD, is a distinguished physician-scientist and healthcare leader. He earned his medical degree from the Medical University of Łódź in 2007 and completed his doctoral training in 2011, followed by post-doctoral research focused on the pathogenesis and biomarkers of monogenic diabetes. In 2020, he was appointed Professor of Medical Sciences.

His research interests include the epidemiology and molecular biology of monogenic diabetes, as well as the clinical application of circulating microRNAs in oncology and radiotherapy. Collaborative projects with Dana-Farber Cancer Institute and Harvard Medical School resulted in the commercialization of a diagnostic test for ovarian cancer and multiple patent filings.

Professor Fendler has authored several hundred peer-reviewed publications in leading scientific journals, including Diabetes Care, Science Translational Medicine, Nature Communications, and Diabetologia. He has served as principal investigator or scientific supervisor for more than 25 nationally and European-funded research projects and is the recipient of numerous prestigious scientific awards and fellowships, including the National Science Centre Award in Life Sciences - the only physician to have received this distinction to date. Since July 2024, he has served as President of the Medical Research Agency of Poland.

“My congratulations to Professor Wojciech Fendler on his appointment as Co-Chair of the Prix Galien Poland Award Committee. Working with leaders whose scientific excellence andintegrity shape the future of healthcare is central to the mission of The Galien Foundation. With this appointment, the Foundation’s presence in Central Europe becomes even stronger and more meaningful,” said Tomasz Hildt, Regional Director Middle East & CEE, The Galien Foundation.

Prix Galien is the world’s most prestigious award recognizing breakthrough achievements in medicine, pharmaceuticals, and healthcare innovation. For more than 50 years, the award has set global benchmarks for excellence in innovative therapies, medical technologies, and solutions that advance clinical practice and patient outcomes. Prix Galien Award Committees worldwide bring together leading figures from the scientific, clinical, and regulatory communities, including internationally recognized experts and Nobel Prize laureates. This ensures that the evaluation process is conducted with the highest standards of scientific rigor, independence, and credibility.

Prix Galien Poland is an integral part of this global network - present in dozens of countries worldwide - and plays a key role in promoting innovative therapies, advanced medical technologies, and initiatives supporting the development of modern healthcare systems.